Ind-Swift Laboratories allots ₹86.96 crore preferential issue
Ind-Swift Laboratories (INDSWFTLAB) said it has allotted preferential issue of ₹86.96 crore. The company is valued at about ₹3,184 crore.
What happened
Ind-Swift Laboratories (INDSWFTLAB) told the exchanges on 8 October 2026 at 06:40 PM that it has allotted preferential issue of ₹86.96 crore.
From the filing: "The details of the allotment are as under: S."
How big is it?
At ₹86.96 crore, the issue is equal to about 2.7% of the company's market value of ₹3,184 crore.
Company snapshot
Ind-Swift Laboratories is a small-cap company, with a market value of about ₹3,184 crore.
The stock last traded at ₹366.1, against a 52-week range of ₹87.15–₹424.8 (13.8% below the high).
Before this filing the shares had moved +0.7% over the month and +58.7% over three months. Average daily turnover over the last 20 sessions was about ₹23.71 crore.
Promoters held 42.93% at the end of Q2 FY27. Foreign institutions owned 10.90% and domestic institutions 0.15%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 153 | 8.8 | 1.28 |
| Q2 FY26 | 153 | 8 | 1 |
| Q3 FY26 | 151 | 9.5 | 1.17 |
| Q4 FY26 | 170 | 15.1 | 1.81 |
| Q1 FY27 | 191 | 24.7 | 2.84 |
What history shows
BCEIE's records show 4 previous fund raising filings from the company since May 2026.
After those filings, the stock fell 0.1% on average the next trading day and was up 3.9% on average after five days (3 filings with price data).
Market-wide, 1,525 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 17 Sept 2026 | Allotment of 70,00,000 Fully Convertible Warrants on Preferential… | +0.3% | +6.9% |
| 4 Sept 2026 | Outcome Of Preferential Issue Committee Meeting Held On Friday, 4Th… | −1.1% | +3.4% |
| 29 Jul 2026 | Outcome Of The Preferential Issue Committee Of The Board Of… | +0.3% | +1.3% |
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.